Analytical Overview: Galectin Therapeutics Inc (GALT)’s Ratios Tell a Financial Story

Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.

As of close of business last night, Galectin Therapeutics Inc’s stock clocked out at $1.19, up 2.59% from its previous closing price of $1.16. In other words, the price has increased by $2.59 from its previous closing price. On the day, 0.6 million shares were traded. GALT stock price reached its highest trading level at $1.29 during the session, while it also had its lowest trading level at $1.175.

Ratios:

To gain a deeper understanding of GALT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.13 and its Current Ratio is at 1.13.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on August 13, 2020, Reiterated its Buy rating but revised its target price to $12 from $9 previously.

On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.

H.C. Wainwright reiterated its Buy rating for the stock on December 07, 2017, while the target price for the stock was revised from $6 to $10.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 30 ’24 when Shlevin Harold H. bought 6,500 shares for $1.16 per share. The transaction valued at 7,540 led to the insider holds 15,206 shares of the business.

Jamil Khurram sold 13,654 shares of GALT for $12,044 on Dec 23 ’24. The Chief Medical Officer now owns 26,346 shares after completing the transaction at $0.88 per share. On Dec 23 ’24, another insider, LEWIS JOEL, who serves as the President and CEO of the company, sold 56,000 shares for $0.89 each. As a result, the insider received 49,610 and left with 897,012 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 74686544 and an Enterprise Value of 241354848.

Stock Price History:

Over the past 52 weeks, GALT has reached a high of $4.27, while it has fallen to a 52-week low of $0.73. The 50-Day Moving Average of the stock is -46.66%, while the 200-Day Moving Average is calculated to be -54.21%.

Shares Statistics:

It appears that GALT traded 666.46K shares on average per day over the past three months and 2492780 shares per day over the past ten days. A total of 62.31M shares are outstanding, with a floating share count of 43.36M. Insiders hold about 30.41% of the company’s shares, while institutions hold 15.65% stake in the company. Shares short for GALT as of 1730332800 were 5517314 with a Short Ratio of 12.41, compared to 1727654400 on 5376378. Therefore, it implies a Short% of Shares Outstanding of 5517314 and a Short% of Float of 18.41.

Most Popular